Journal of Immunology Research / 2015 / Article / Tab 5

Research Article

Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity

Table 5

Comparability of the primary endpoint between treatments.

Patients
ArmsStudent’s -test
Wilcoxon

10 versus 131 versus 20.51140.5558
38 versus 131 and 3 versus 20.57420.6421
37 versus 131 and versus 20.86030.7401

Exclusion of one outliner.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.